[Skip to Navigation]
Comment & Response
November 15, 2021

Safety of Early Discontinuation of Antiseizure Medication After Acute Symptomatic Neonatal Seizures

Author Affiliations
  • 1Department of Neurosciences and Pediatrics, University of California, San Diego, San Diego
  • 2Rady Children’s Hospital–San Diego, San Diego, California
JAMA Neurol. 2022;79(1):90-91. doi:10.1001/jamaneurol.2021.4109

To the Editor We read with great interest the study from Glass et al1 exploring the conundrum of continuation vs cessation of antiseizure medication (ASM) after acute symptomatic neonatal seizures. The study represents, to our knowledge, the largest and most systematic on the topic and is an important step toward an evidence-based approach to ASM use in this vulnerable population.

Add or change institution